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Sodium excretionHypoxia inducible factor (HIF)-1α-mediated gene activation in the renal medulla in response to high salt in-
take plays an important role in the control of salt sensitivity of blood pressure. High salt-induced activation of
HIF-1α in the renal medulla is blunted in Dahl S rats. The present study determined whether the impairment
of the renal medullary HIF-1α pathway was responsible for salt sensitive hypertension in Dahl S rats. Renal
medullary HIF-1α levels were induced by either transfection of HIF-1α expression plasmid or chronic infu-
sion of CoCl2 into the renal medulla, which was accompanied by increased expressions of anti-
hypertensive genes, cyclooxygenase-2 and heme oxygenase-1. Overexpression of HIF-1α transgenes in the
renal medulla enhanced the pressure natriuresis, promoted the sodium excretion and reduced sodium reten-
tion after salt overload. As a result, hypertension induced by 2-week high salt was signiﬁcantly attenuated in
rats treated with HIF-1α plasmid or CoCl2. These results suggest that an abnormal HIF-1α in the renal medul-
la may represent a novel mechanism mediating salt-sensitive hypertension in Dahl S rats and that induction
of HIF-1α levels in the renal medulla could be a therapeutic approach for the treatment of salt-sensitive
hypertension.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Salt-sensitive hypertension accounts for 50% of hypertensive pop-
ulation [1,2]. Importantly, the salt sensitivity of blood pressure is
closely associated with a much greater propensity to develop organ
injuries in hypertension [2–4]. Mechanism for salt-sensitive hyper-
tension is not fully understood. It is well documented that renal med-
ullary function plays an important role in the regulation of renal
sodium excretion and arterial blood pressure, and that dysfunction
in the renal medulla is involved in salt-sensitive hypertension
[5–10]. We have recently demonstrated that the transcription factor
hypoxia inducible factor (HIF)-1α-mediated gene activation in the
renal medulla is an important adaptive mechanism in response to
high salt intake, which leads to inductions of various protective fac-
tors in the renal medulla and promotes extra sodium excretion [11].
HIF-1α and some of its target genes, such as nitric oxide synthase
(NOS), cyclooxygenase-2 (COX-2) and hemeoxygenase-1 (HO-1), are
highly expressed in the renal medulla [6,10,12–15]. These HIF-1α tar-
get genes in the renal medulla are up-regulated in response to high
salt intake [6,13–16]. The products of these genes play critical roles
in regulating renal medullary blood ﬂow and tubular activity, andogy & Toxicology, Medical Col-
ersity, P.O. Box 980613, Rich-
828 4794.
l rights reserved.thereby maintaining the constancy of body ﬂuid volume and arterial
blood pressure [6,10,13,14,17–19]. Interestingly, inhibition of these
genes and/or the enzymes encoded by these genes within the renal
medulla reduces sodium excretion and increases salt sensitivity of ar-
terial blood pressure [6,10,13,14,17–19]. We previously showed that
high salt intake increased HIF-1α levels in the renal medulla
[11], and that inhibition of HIF-1α blocked the activation of its
target genes in the renal medulla in response to high salt intake and
promoted sodium retention, consequently producing salt-sensitive
hypertension [11]. This previous study was carried out in normoten-
sive animals and suggested that HIF-1α-mediated gene regulation
in the renal medulla represents an important molecular adaptive
mechanism in response to high salt intake and plays a crucial role in
the maintenance of sodium balance. However, it remains unknown
whether renal medullary HIF-1α pathway is involved in the develop-
ment of hypertension in salt-sensitive individuals.
Dahl salt sensitive hypertensive rat is a widely used genetic model
of human salt-sensitive hypertension that exhibits many phenotypic
characteristics in common with human hypertension [3,20–23].
Renal medullary dysfunction is one of the major mechanisms for
this rat strain to develop hypertension [7–10]. Most interestingly,
the above protective genes regulated by HIF-1α has been shown to
be impaired in this animal model and deﬁciencies of these HIF-1α tar-
get genes in the renal medulla are considered to be responsible for
the development of hypertension in Dahl S rats [9,10,24–27]. We re-
cently showed that upregulation of HIF-1α levels in response to high
salt intake was blunted in the renal medulla in Dahl S rats [28]. We
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protective genes are due to a defect in renal medullary HIF-1α and
that impairment in HIF-1α-mediated gene activation in the renal me-
dulla is responsible for salt sensitive hypertension in Dahl S rats. In
the present study, we induced the expression of HIF-1α levels in
the renal medulla by overexpression of HIF-1α transgenes or infusion
of CoCl2, a HIF-1α inducer, into the renal medulla and then deter-
mined the improvement of renal sodium handling and salt-sensitive
hypertension in this animal model. Our results suggested that resto-
ration of the deﬁcit in HIF-1α-mediated gene activation in the renal
medulla attenuated salt-sensitive hypertension through the improve-
ment of sodium excretion in Dahl S rats.2. Materials and Methods
2.1. Animal
Experiments were performed in male Dahl S rats (Charles River,
Wilmington, MA), weighing 250–350 g. Animals were kept on a low
salt diet (0.4%NaCl) and some of them were fed with a high salt diet
(4% NaCl) during experiments as indicated in the results section. All
animal procedures were approved by the Institutional Animal Care
and Use Committee of the Virginia Commonwealth University.2.2. Transfection of DNA into the renal medulla
Rats were uninephrectomized one week before, and the remain-
ing left kidney was transfected with plasmids encoding human HIF-
1α (50 μg) (Addgene, Cambridge, MA) into the renal medulla using
in vivo-jetPEI™ (Polyplus-transfection, New York, NY), a polyethyleni-
mine derivative, in combination with ultrasound radiation as we de-
scribed before [28]. We used human HIF-1α plasmids because that
rat HIF-1α plasmids were not available and that the hypoxia response
elements in HIF-1α target genes are conservative among human-rat-
mouse [29,30]. We also conﬁrmed that transfection of these human
HIF-1α plasmids into cultured rat cells remarkably increased the ex-
pression of HIF-1α target genes HO-1 and COX-2 in preliminary ex-
periment. Plasmids expressing luciferase were used in control
animals.2.3. Chronic renal medullary infusion of CoCl2
The rats were uninephrectomized and anesthetized as above. To
implant the renal medullary infusion catheter, the left kidney was ex-
posed by a ﬂank incision (1–1.5 cm), and a medullary interstitial
catheter (tapered tip, 4-5 mm) was implanted into the kidney. The
catheter was made with a number of circular “pig-tail” bends,
which prevented the catheter from being pulled out of the kidney
during normal movement of the animal. The catheter was anchored
into place on the kidney surface with Vetbond Tissue Adhesive
(3 M) and a small piece of fat tissue. These catheters were tunneled
to the back of neck and connected to an osmotic pump (ALZET,
model 2ML2), which contained CoCl2 (2 mmol/L) and was implanted
subcutaneously. This technique has been successfully used for chronic
infusion into the kidneys previously [31–34]. We also conﬁrmed the
successfully chronic infusion using this method by visualizing the de-
livery of a red dye into the renal medulla and checking no solution left
in the pump in preliminary experiments. At the end of experiment,
kidneys were removed and rapidly dissected into the renal cortex
and medulla and then frozen in liquid N2. The precise location of in-
terstitial infusion catheter was determined when dissecting kidney
tissue. No solution remained in the osmotic pump was also checked
and conﬁrmed at the end.2.4. Measurement of pressure natriuresis in response to the elevations of
renal perfusion pressure
Animals were transfected with HIF-1α or control plasmids as de-
scribed above and maintained on low salt diet. Ten days after trans-
fection, pressure natriuresis studies were performed as described
previously [6,35].
2.5. Measurement of urinary sodium excretion in response to acute
sodium loading
Additional groups of animals transfected with HIF-1α or control
plasmids as above were surgically prepared similar to that in the
pressure natriuresis studies and received a continuous infusion of
0.9% NaCl solution containing 2% albumin at a rate of 1 ml/hr/100 g
BW throughout the experiment to replace ﬂuid loss. After 1-hour
equilibration and two 10-min control period sample collections, a
5% body weight isotonic saline load was administered intravenously
and three 10-min samples were collected over 30 minutes [11,36],
and then three more 10-min post-control samples were taken. Uri-
nary volume and sodium excretion were measured.
2.6. Measurement of daily sodium balance
Additional groups of animals the same as above were housed in
metabolic cages and daily indexes of sodium balance were computed
by subtracting urinary sodium excretion from total sodium intake.
After 1 day of control measurements, the animals were switched
from tap water to 2% NaCl water and experimental measurements
were continued for 3 days [37,38].
2.7. Chronic monitoring of arterial blood pressure in conscious rats
A telemetry transmitter (Data Sciences International) was
implanted for the measurement of mean arterial blood pressure
(MAP) as we described previously [6]. After baseline MAP was
recorded on 3 consecutive control days while the rats remained on
low salt diet, animals were switched to high salt diet (Dyets, Inc)
and MAP was recorded for additional 2 weeks. Four groups of ani-
mals, including rats treated with control plasmids (Ctrl)+low salt
diet (LS), Ctrl+high salt diet (HS), HIF-1α plasmids+HS and
CoCl2+HS, were examined. At the end of experiment, renal tissues
were collected for protein and RNA isolation later.
2.8. Preparation of tissue homogenate and nuclear extracts and Western
blot analyses for protein levels of HIF-1α
Renal tissue homogenates and nuclear protein were prepared, and
Western blot analyses were performed as described previously
[39,40]. Species reactivity of the primary antibody used in the present
study included both rat and human (monoclonal, Novus Biologicals,
1:300 dilution). The intensities of the blots were determined using
an imaging analysis program (ImageJ, free download from http://
rsbweb.nih.gov/ij/).
2.9. RNA extraction and quantitative RT-PCR analysis of heme oxygenase
(HO)-1 and cyclooxygenase (COX)-2 mRNA
Total RNA from renal medulla was extracted using TRIzol solution
(Life Technologies, Inc. Rockville MD) and then reverse-transcribed
(RT) (cDNA Synthesis Kit, Bio-Rad, Hercules, CA). The RT products
were ampliﬁed using TaqMan Gene Expression Assays kits (Applied
Biosystems). The level of 18S ribosomal RNA was used as an endoge-
nous control. The relative gene expressions were calculated in accor-
dance with the ΔΔCt method. Relative mRNA levels were expressed
by the values of 2-ΔΔCt.
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Data are presented as means±SE. The signiﬁcance of differences
in mean values within and between multiple groups was evaluated
using an ANOVA followed by a Duncan's multiple range test. Stu-
dent's t-test was used to evaluate statistical signiﬁcance of differences
between two groups. Pb0.05 was considered statistically signiﬁcant.
3. Results
3.1. Effect of renal medullary transfection of HIF-1α or CoCl2 infusion on
the levels of HIF-1α and its target genes in the renal medulla
As shown in Fig. 1, high salt intake failed to signiﬁcantly upregu-
late HIF-1α protein levels in the renal medulla in this animal strain,
which was consistent with previous report [28]. However, HIF-1α
levels were signiﬁcantly increased in the renal medulla from rats
treated with HIF-1α plasmids or CoCl2 after high salt diet (Fig. 1).
The mRNA levels of two important HIF-1α target genes, HO-1 and
COX2, in the renal medulla were shown in Fig. 2. Similar to the pat-
terns of HIF-1α protein levels, both HO-1 and COX2 transcriptions
were remarkably activated in rats treated with HIF-1α plasmids or
CoCl2. Although the increases of these HIF-1α target genes in high
salt alone group were statistically signiﬁcant, these responses to
high salt intake were marginal and considerably blunted compared
with the responses of 3–4 fold increases in normal rats [11]. Treat-
ments with HIF-1α plasmids and CoCl2 recovered the impaired re-
sponses of these protective genes transcriptions after high salt
challenge. These results veriﬁed the successful induction of HIF-1α-
mediated gene activation in the renal medulla by HIF-1α plasmids
or CoCl2.
3.2. Effects of renal medullary transfection of HIF-1α transgenes on
pressure natriuresis in response to the elevations of renal perfusion
pressure (RPP)
Both the urine ﬂow and urinary sodium excretion rates were in-
creased in response to the elevation of RPP. However, these pressureLS      HS          HS +
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Fig. 1. Effects of renal medullary transfection of HIF-1α transgene or CoCl2 infusion on
HIF-1α levels in the renal medulla. A: Representative ECL gel documents of Western
blot analyses depicting the protein levels of HIF-1α. B: Summarized intensities of the
HIF-1α blots (ratio to β-actin). * Pb0.05 vs. control (n=6). LS=low salt+control vec-
tors, HS=high salt+control vectors, HIF-1α=HIF-1α expression vectors, CoCl2=CoCl2
infusion.diuretic and natriuretic responses were signiﬁcantly enhanced in HIF-
1α plasmids-transfected rats compared with the control group
(Fig. 3).0
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Fig. 5. Effects of renalmedullary transfection ofHIF-1α transgene on salt balances. A: daily
sodium balance. B: cumulative sodium balance. * Pb0.05 vs. HIF-1α (n=6).
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urinary sodium excretion in response to acute sodium loading
Acute sodium loading increased urine volume (U·V) and urinary
sodium excretion (UNa·V). These increases in U·V and UNa·V were
considerably enhanced in rats treated with HIF-1α plasmids com-
pared with control (Fig. 4).
3.4. Effects of renal medullary transfection of HIF-1α transgeness on salt
balance
High salt intake induced a positive daily and cumulative salt bal-
ance. The daily positive salt balances were progressively increased
in the ﬁrst two days and decreased on the third day of high salt in-
take. The high salt-induced positive salt balance was signiﬁcantly at-
tenuated in rats treated with HIF-1α plasmids compared with control
rats (Fig. 5).
3.5. Effects of renal medullary transfection of HIF-1α transgenes or infu-
sion of CoCl2 on arterial blood pressure
There was no difference in baseline mean arterial pressure (MAP)
among animas treated with control and HIF-1α plasmids as well as
CoCl2 when the animals were fed with a low salt diet. After the rats
were challenged with a high salt diet, the MAP were progressively in-
creased from 113±0.9 to 150±7.03 mmHg in control rats. Both
treatments of HIF-1α plasmids and CoCl2 remarkably blocked the
HS-induced increase in MAP. MAP was only increased to 129±
3.1 mmHg in both HIF-1α plasmid-and CoCl2-treated groups by the
end of the experiment (Fig. 6).
4. Discussion
The present study demonstrated that induction of HIF-1α-
mediated gene activation in the renal medulla stimulated the0
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Fig. 4. Effects of renal medullary transfection of HIF-1α transgene on U·V (A) and
UNa·V (B) in response to acute Na+ loading. * Pb0.05 vs. control (n=6). S=sodium
loading; P=post sodium loading.expression of anti-hypertensive genes in the renal medulla, and con-
sequently enhanced the urinary sodium excretion in response to the
elevations of RPP and sodium overloading, reduced sodium retention,
as a result, attenuated the salt-sensitive hypertension in Dahl S rats.
Our results showed that local delivery of HIF-1α plasmids or CoCl2
substantially up-regulated the levels of HIF-1α and enhanced the
transcription of its target genes in the renal medulla, which validated
the manipulation of HIF-1α-mediated gene regulation in the renal
medulla and allowed us to evaluate the contribution of HIF-1α-
mediated gene activation in the development of hypertension in re-
sponse to high salt intakes in Dahl S rats.
We ﬁrst determined the effects of up-regulation in HIF-1α-
mediated gene activation on pressure natriuresis. Renal medullary
function plays an important role in the regulation of pressure natri-
uresis [8,41–43] and several HIF-1α target genes such as HO-1,
COX-2 and NOS have been reported to be crucial regulators in renalFig. 6. Effects of renal medullary transfection of HIF-1α transgene or CoCl2 infusion on
mean arterial pressure (MAP). * Pb0.05 vs. others. (n=6).
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uresis [12,43–46]. Pressure natriuresis has been shown to be signiﬁ-
cantly blunted in Dahl S rats [47–50]. Interestingly, renal medullary
levels of the above enzymes are much lower [9,24,25] and their
responses to high salt diet are diminished [9,10,26,27] in Dahl S
rats. Increase of HIF-1α levels would be expected to activate the tran-
scriptions of these HIF-1α target genes in the renal medulla, thereby
improving pressure natriuresis relationship. Our data showed that
transfection of HIF-1α plasmids into the renal medulla signiﬁcantly
enhanced the pressure natriuresis, suggesting that impaired HIF-1α
pathway may be responsible for the renal medullary dysfunction in
Dahl S rats. Since the products of the enzymes encoded by these
HIF-1α target genes have been shown to dilate the medullary vascu-
lature and inhibit the tubular activities [8,41,42,51], the effect of HIF-
1α-mediated pathway on pressure natriuresis may be through both
vascular and tubular actions.
To further evaluate the impact of renal medullary HIF-1α defect
on salt handling, we examined the sodium excretion after acute sodi-
um loading and salt balance after chronic sodium challenge. Because
high salt-induced up-regulation of HIF-1α levels in the renal medulla
is blunted in Dahl S rats, the impairment in those anti-hypertensive
factors, such as COX2 and HO-1, in the renal medulla is probably at-
tributed to the defect in HIF-1α response after high salt challenge in
this animal model. Correction of the defect in HIF-1α-mediated
gene activation in the renal medulla would improve the salt handling
in Dahl S rats. The results from these extra sodium loading experi-
ments demonstrated that restoration of renal medullary HIF-1α
levels remarkably improved the capability of the kidneys to remove
extra sodium load, which reduced sodium retention. These data addi-
tionally suggest that deﬁciency in renal medullary HIF-1α pathway
may contribute to the impaired regulation of sodium excretion in
Dahl S rats.
Since pressure-natriuresis and normal renal medullary function
are key determinants to the long-term control of arterial blood pres-
sure [7,8,41,42,52], the improvement in sodium excretions in re-
sponses to RPP and extra sodium loading would lead to an decrease
in MAP in response to high salt intake in Dahl S rats. To test this hy-
pothesis, we compared MAPs between animals transfected with
HIF-1α and control plasmids into the renal medulla. It was found
that high salt-induced increase in MAP was signiﬁcantly blocked in
HIF-1α plasmids-treated rats. An alternative way to induce HIF-1α
by CoCl2 infusion achieved a similar result to block high salt-
induced hypertension. It has been shown that high salt-induced acti-
vation of HIF-1α-regualted pathways is considered as an adaptive
mechanism to high salt intake, which leads to an induction of various
protective factors and promotes extra sodium excretion [11]. There-
fore, deﬁciency of HIF-1α-mediated gene transcription in the renal
medulla may decrease the production of various protective factors,
impair renal medullary function, damage the capability of the kidneys
to remove extra sodium load, consequently disrupt salt adaptation
and increase the salt sensitivity of arterial blood pressure in Dahl S
rats. This deﬁciency in HIF-1α-mediated gene activation may repre-
sent an important mechanism for the development of salt sensitive
hypertension. Induction of HIF-1α in the renal medulla may restore
the molecular adaptation to high salt intake and stimulate the pro-
duction of different renal medullary protective or antihypertensive
factors, thereby, attenuate salt-sensitive hypertension.
The present study did not attempt to explore the mechanisms that
caused the impaired HIF-1α response to high salt in Dahl rats. In this
regard, HIF-prolyl hydroxylases, the enzymes that promote the
degradation of HIF-1α, may be accountable for it. HIF prolyl-
hydroxylases catalyze site-speciﬁc proline hydroxylation of HIF-1α
and then the hydroxylated HIF-1α is recognized and targeted for deg-
radation by the ubiquitin-proteasome pathway [53,54]. Three iso-
forms of HIF prolyl-hydroxylase, including prolyl hydroxylase
domain-containing proteins 1, 2, and 3 (PHD1, 2, and 3), have beenidentiﬁed [53,55,56]. PHDs are present in the kidneys with PHD2 as
the predominant isoform [39,57–60] and PHD2 is most abundantly
expressed in the renal medulla [39,60]. It has been shown that high
salt-induced inhibition of PHD2 in the renal medulla may be the up-
stream mediator for the activation of renal medullary HIF-1α in re-
sponse to high salt challenge [28]. A defect in renal medullary PHD2
could be responsible for the impairment of HIF-1α-mediated salt
adaptive pathway in Dahl S rats [28]. Detailed mechanisms associated
with renal medullary PHD2 in salt adaptation need to be clariﬁed in
future investigations.
In summary, the present study demonstrated that up-regulation
of HIF-1α levels in the renal medulla stimulated the transcription of
enzymes that produce anti-hypertensive factor in the renal medulla,
which corrected the defect in HIF-1α-mediated renal adaptation in
response to high salt intake. As a result, this correction improved so-
dium excretion and attenuated salt-sensitive hypertension in Dahl S
rats. It is concluded that deﬁciency in HIF-1α-mediated gene activa-
tion may be responsible for the hypertension in Dahl S rats and cor-
rection of this defect may be used to as a therapeutic strategy for
salt-sensitive hypertension.
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